| Announce Date | 11/26/2025 |
| EPS Normalized Actual | $3.93 (Beat by $0.09) |
| EPS GAAP Actual | $3.93 (Beat by $0.09) |
| Revenue Actual | $12.394B |
| Revenue Surprise | Beat by $12394M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Oct 2028 | 28.9689 | 20.22 | 27.67953 | 30.67223 | 6 |
| Oct 2028 | 44.0764 | 13.29 | 41.20061 | 47.14705 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 3.94 | 3.94 | 12.394B | 12.64% | 12394M |
| FQ3 2025 (Jul 2025) | 4.76 | 4.76 | 11.783B | -11.62% | 11783M |
| FQ2 2025 (Apr 2025) | 6.6544 | 6.6544 | 12.525B | -21.64% | 12525M |
| FQ1 2025 (Jan 2025) | 3.2 | 3.2 | 6.809B | -78.95% | 6809M |
| FQ4 2024 (Oct 2024) | 0 | 0 | 10.827B | -40% | 10827M |
| FQ3 2024 (Jul 2024) | 6.29 | 6.29 | 13.152B | 100% | 13152M |
| FQ2 2024 (Apr 2024) | 8.56 | 8.56 | 15.235B | -14.13% | 15235M |
| FQ1 2024 (Jan 2024) | 6.23 | 6.23 | 12.185B | -3.83% | 12185M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Nov 2028) | 7.35707 | -- | 7.0237 | 7.59357 | 10 |
| FQ3 2028 (Jul 2028) | 7.33063 | -- | 7.03211 | 7.60893 | 5 |
| FQ2 2028 (Apr 2028) | 7.7217 | -- | 7.40725 | 8.01485 | 5 |
| FQ1 2028 (Jan 2028) | 3.13437 | -- | 3.00673 | 3.25336 | 5 |
| FQ4 2027 (Oct 2027) | 7.01079 | -- | 6.60043 | 7.51147 | 7 |
| FQ3 2027 (Jul 2027) | 6.89133 | -- | 6.48796 | 7.38348 | 9 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Nov 2028) | 12.89B | -- | 12.44B | 13.21B | 6 |
| FQ3 2028 (Jul 2028) | 12.48B | -- | 12.09B | 12.85B | 3 |
| FQ2 2028 (Apr 2028) | 13.13B | -- | 12.72B | 13.51B | 5 |
| FQ1 2028 (Jan 2028) | 8.7B | -- | 8.43B | 8.96B | 3 |
| FQ4 2027 (Oct 2027) | 11.72B | -- | 11.2B | 12.37B | 5 |
| FQ3 2027 (Jul 2027) | 11.41B | -- | 10.9B | 12.04B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 3.94 | 3.94 | 100% | |
| FQ3 2025 (Jul 2025) | 4.76 | 4.76 | 100% | |
| FQ2 2025 (Apr 2025) | 6.6544 | 6.6544 | 100% | |
| FQ1 2025 (Jan 2025) | 3.2 | 3.2 | 100% | |
| FQ4 2024 (Oct 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Jul 2024) | 6.29 | 6.29 | 100% | |
| FQ2 2024 (Apr 2024) | 8.56 | 8.56 | 100% | |
| FQ1 2024 (Jan 2024) | 6.23 | 6.23 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $12.39B | $12394M | 100% |
| FQ3 2025 (Jul 2025) | $0B | $11.78B | $11783M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $12.53B | $12525M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $6.81B | $6809M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $10.83B | $10827M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $13.15B | $13152M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $15.24B | $15235M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $12.19B | $12185M | 100% |